Sacubitril-valsartan improves conduit vessel function and functional capacity and reduces inflammation in heart failure with reduced ejection fraction

Kanokwan Bunsawat(University of Utah), D. Walter Wray, Stephen M. Ratchford(University of Utah), Josef Stehlik, Jeremy K. Alpenglow(University of Utah), Soung Hun Park(University of Utah), Adam S. Smith(University of Kansas), Catherine L. Jarrett(University of Utah), Russell S. Richardson(University of Utah)
Journal of Applied Physiology
November 19, 2020
Cited by 32


Related Papers